Bristol-Myers Squibb Co. (BMY) Falls 3.21% for February 02

Equities Staff |

One of the S&P 500’s big losers for Tuesday February 02 was Bristol-Myers Squibb Co. (BMY). The company’s stock fell 3.21% to $58.87 on volume of 6.95 million shares.

The stock opened the day at 60.03 and traded between a low of $58.65 and a high of $60.30. The stock finished the day down $1.95 per share. Bristol-Myers Squibb Co. has an average daily volume of 6.72 million and a total float of 1.67 billion shares. The 50-day SMA for Bristol-Myers Squibb Co. is $66.30 and its 200-day SMA is $64.42. The high for the stock over the last 52 weeks is $70.87 and the low is $51.82.

Bristol-Myers Squibb Co is a biopharmaceutical company. It discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products.

Bristol-Myers Squibb Co. is centered in New York, NY, and has 25,000 employees. Today’s trading day leaves the company with a market cap of $98.21 billion. The company has a P/S ratio of n/a, P/B ratio of 6.43, and a n/a.

For a complete fundamental analysis analysis of Bristol-Myers Squibb Co., check out Equities.com’s Stock Valuation Analysis report for BMY. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.



DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Sugarmade Inc

Sugarmade Inc is engaged in marketing and distribution of environmental friendly non-tree-based paper products.

Private Markets

Voleo

Voleo is a free download that allows you to form investment clubs with your friends, family, colleagues, classmates, teammates…basically anyone you know and trust. Invest and manage a stock portfolio…

The Green Organic Dutchman

The Green Organic Dutchman Ltd. ("TGOD") produces farm grown, organic cannabis for medical use. The company grows its high quality organic cannabis in small batches using craft growing, all natural…